A citation-based method for searching scientific literature

Danika Scott, Sue Friedman, Melinda L Telli, Allison W Kurian. JCO Oncol Pract 2020
Times Cited: 6







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
66

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
50

Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
41
33

Access to Genetic Counselors in the Southern United States.
Catalina Villegas, Susanne B Haga. J Pers Med 2019
11
33

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
Steven J Katz, Kevin C Ward, Ann S Hamilton, M Chandler Mcleod, Lauren P Wallner, Monica Morrow, Reshma Jagsi, Sarah T Hawley, Allison W Kurian. J Clin Oncol 2018
36
33

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
33

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
Kenneth Offit, Kaitlyn A Tkachuk, Zsofia K Stadler, Michael F Walsh, Hector Diaz-Zabala, Jeffrey D Levin, Zoe Steinsnyder, Vignesh Ravichandran, Ravi N Sharaf, Melissa K Frey,[...]. J Clin Oncol 2020
12
33

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
223
33

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
Melissa K Frey, Ryan M Kahn, Eloise Chapman-Davis, Francesca Tubito, Maira Pires, Paul Christos, Samantha Anderson, Semanti Mukherjee, Bailey Jordan, Stephanie V Blank,[...]. J Clin Oncol 2020
17
33

The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.
Alejandra Hurtado-de-Mendoza, Monica C Jackson, Lyndsay Anderson, Vanessa B Sheppard. J Genet Couns 2017
7
33

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
50
33

African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.
Vanessa B Sheppard, Kristi D Graves, Juleen Christopher, Alejandra Hurtado-de-Mendoza, Costellia Talley, Karen Patricia Williams. J Genet Couns 2014
31
33

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
644
33

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
K Metcalfe, S Gershman, H T Lynch, P Ghadirian, N Tung, C Kim-Sing, O I Olopade, S Domchek, J McLennan, A Eisen,[...]. Br J Cancer 2011
116
16

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.
Tehillah S Menes, Mary Beth Terry, David Goldgar, Irene L Andrulis, Julia A Knight, Esther M John, Yuyan Liao, Melissa Southey, Alexander Miron, Wendy Chung,[...]. Breast Cancer Res Treat 2015
14
16

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.
Mohamed Salhab, Selina Bismohun, Kefah Mokbel. BMC Womens Health 2010
41
16

Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
41
16

Differences in BRCA counseling and testing practices based on ordering provider type.
Deborah Cragun, Lucia Camperlengo, Emily Robinson, Meghan Caldwell, Jongphil Kim, Catherine Phelan, Alvaro N Monteiro, Susan T Vadaparampil, Thomas A Sellers, Tuya Pal. Genet Med 2015
27
16

Confronting genetic testing disparities: knowledge is power.
Michael Hall, Olufunmilayo I Olopade. JAMA 2005
63
16

Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Leland E Hull, Jennifer S Haas, Steven R Simon. Am J Prev Med 2018
12
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16


Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
16

Impact of Payer Constraints on Access to Genetic Testing.
Pat Whitworth, Peter Beitsch, Christopher Arnell, Hannah C Cox, Krystal Brown, John Kidd, Johnathan M Lancaster. J Oncol Pract 2017
23
16

Health and Racial Disparity in Breast Cancer.
Clement G Yedjou, Jennifer N Sims, Lucio Miele, Felicite Noubissi, Leroy Lowe, Duber D Fonseca, Richard A Alo, Marinelle Payton, Paul B Tchounwou. Adv Exp Med Biol 2019
27
16

Mutations in context: implications of BRCA testing in diverse populations.
Gabriela E S Felix, Yonglan Zheng, Olufunmilayo I Olopade. Fam Cancer 2018
11
16

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.
Carlos H Barcenas, Maryam N Shafaee, Arup K Sinha, Akshara Raghavendra, Babita Saigal, Rashmi K Murthy, Ashley H Woodson, Banu Arun. J Natl Compr Canc Netw 2018
8
16

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
16

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
112
16

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
82
16

Genetics workforce: distribution of genetics services and challenges to health care in California.
Monica Penon-Portmann, Jiyoo Chang, Mira Cheng, Joseph T Shieh. Genet Med 2020
14
16

Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study.
Jennifer M Hoskovec, R L Bennett, M E Carey, J E DaVanzo, M Dougherty, S E Hahn, B S LeRoy, S O'Neal, J G Richardson, C A Wicklund. J Genet Couns 2018
114
16

Clinical genetics issues encountered by family physicians.
Louise S Acheson, Kurt C Stange, Stephen Zyzanski. Genet Med 2005
42
16

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
16

Risk-reducing mastectomy for the prevention of primary breast cancer.
Nora E Carbine, Liz Lostumbo, Judi Wallace, Henry Ko. Cochrane Database Syst Rev 2018
81
16

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Lori J Pierce, Kelly-Anne Phillips, Kent A Griffith, Saundra Buys, David K Gaffney, Meena S Moran, Bruce G Haffty, Merav Ben-David, Bella Kaufman, Judy E Garber,[...]. Breast Cancer Res Treat 2010
100
16


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
185
16

Impact of a genetic counseling requirement prior to genetic testing.
David D Stenehjem, Trang Au, Amy M Sainski, Hillevi Bauer, Krystal Brown, Johnathan Lancaster, Vanessa Stevens, Diana I Brixner. BMC Health Serv Res 2018
14
16

Recruitment of black women for a study of inherited breast cancer using a cancer registry-based approach.
Tuya Pal, Erin Rocchio, Ana Garcia, Desiree Rivers, Susan Vadaparampil. Genet Test Mol Biomarkers 2011
20
16

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
16


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
16

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
37
16

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Esme Finlay, Jill E Stopfer, Eric Burlingame, Katherine Goldfeder Evans, Katherine L Nathanson, Barbara L Weber, Katrina Armstrong, Timothy R Rebbeck, Susan M Domchek. Genet Test 2008
98
16

Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
Kenneth Offit, Angela Bradbury, Courtney Storm, Jon F Merz, Kevin E Noonan, Rebecca Spence. J Clin Oncol 2013
34
16

Cancer genomics and inherited risk.
Zsofia K Stadler, Kasmintan A Schrader, Joseph Vijai, Mark E Robson, Kenneth Offit. J Clin Oncol 2014
86
16

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
Megan C Roberts, W David Dotson, Christopher S DeVore, Erica M Bednar, Deborah J Bowen, Theodore G Ganiats, Ridgely Fisk Green, Georgia M Hurst, Alisdair R Philp, Charité N Ricker,[...]. Health Aff (Millwood) 2018
49
16


Health-care professionals' responsibility to patients' relatives in genetic medicine: a systematic review and synthesis of empirical research.
Sandi Dheensa, Angela Fenwick, Shiri Shkedi-Rafid, Gillian Crawford, Anneke Lucassen. Genet Med 2016
44
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.